0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Analyst Opinions

    New
    $695 | March 2024
    Analyst Opinions
    New

    Development of Electric Mining Vehicles in Surface and Underground Mining, 2024

    As miners strive to reduce greenhouse gas emissions, many are beginning to invest in battery-powered and electric-powered mining fleets as they embark on the long-term goal of diesel displacement. 'The pace of switching to electric mining vehicles is increasing. Underground over 320 LHDs and mining trucks were running on electric power by March 2024, while for surface mines the use of electric-powered mining trucks has been picking up with almost 240 trolley-assist trucks and 129 battery-powered surface trucks.

  • Sector Analysis

    New
    $2,750 | May 2024
    Sector Analysis
    New

    Morocco Cards and Payments – Opportunities and Risks to 2028

    Morocco Cards and Payments Market Report Overview The annual value of card transactions in the Morocco cards and payments market was $6.3 billion in 2023 and will grow at a CAGR of more than 12% during 2024-2028. Cash remains a strong preference for Moroccan consumers. However, the government and banks are striving to increase awareness levels to encourage electronic payments. Morocco Card Transactions Outlook, 2023-2028 ($ Billion) Buy the Full Report for More Information on the Morocco Cards and Payments...

  • Thematic Analysis

    New
    $995 | April 2024
    Thematic Analysis
    New

    Digital Twins in Oil and Gas – Thematic Intelligence

    Digital Twins in Oil and Gas Thematic Report Overview Digital twins are digital representations of physical assets, systems, people, or processes. They help detect, prevent, predict, and optimize the physical environment using artificial intelligence (AI), real-time analytics, visualization, and simulation tools. Digital twins are rapidly becoming a mainstay in oil and gas operations as companies strive to optimize asset performance and minimize unplanned outages. This aims to make oil and gas operations relatively safer while lowering the carbon footprint and...

  • Sector Analysis

    $995 | November 2023
    Sector Analysis

    Green Bites – Key Disruptive Forces in Sustainable Nutrition

    Disruptive Forces in Sustainable Nutrition Report Overview Advanced developments such as edible insects, food 3D printing, and plant-based proteins are redefining food efficiency and environmental impact in the sustainable nutrition domain. Innovation Curve: Consumer Buy the Full Report to Know More about the Disruptive Forces in Sustainable Nutrition Download a Free Report Sample The ‘Green Bites – Key Disruptive Forces in Sustainable Nutrition’ FutureTech series report categorizes the key innovation areas in sustainable nutrition as emerging, accelerating, and maturing. The...

  • Case Studies

    $1,495 | September 2023
    Case Studies

    Luxury Train Travel in India – Case Study

    Luxury Train Travel in India Overview India has flourished as a tourist spot due to its diverse landscapes, rich heritage, and lively culture. Amidst the growth of the tourism market, luxury train travel has steadily gained popularity over the past few years as a diverse travel experience. Luxury train travel in India has a rich historical legacy that can be traced back to the era of the British Raj (British Rule). By undergoing a profound transformation, luxury trains have overcome...

  • Company Profile

    $295 | February 2024
    Company Profile

    enVVeno Medical Corp – Company Profile

    enVVeno Medical Corp (enVVeno Medical) is a medical equipment company. The company strives to design, develop, manufacture and commercialize implantable bioprosthetic medical devices. It’s product portfolio comprises VenoValveo, which is developed based on porcine tissue to treat lower limb chronic deep vein insufficiency, bioprosthetic heart valve for pediatric aortic and mitral valve replacement and CoreoGrafto, a bovine tissue-based off the shelf conduit that is developed for coronary artery bypass surgery, enVVe for non-surgical replacement venous valve for treatment of chronic...

    Add to Basket
  • Company Profile

    $295 | February 2024
    Company Profile

    Cue Health Inc – Company Profile

    Cue Health Inc (Cue Health) operates as a healthcare technology company that strives to design, develop, manufacture and commercialize medical diagnostic products for use in home and clinical settings. The company’s products includecue reader, covid-19 test, mpox (monkeypox) test, cue test kits, medications, cue care, cue+ membership, food sensitivity panel, cue reader, cardiac risk Apo A+B test reader, liver panel reader, colon cancer screening reader, women's sexual health panel kit, men sexual health panel kit, herpes panel, women's health panel,...

    Add to Basket
  • Company Profile

    $295 | February 2024
    Company Profile

    Precision Biosciences Inc – Company Profile

    Precision Biosciences Inc (Precision BioSciences) is a biotechnology company, that develops and commercializes gene therapy and cancer immunotherapy. The company intends to its ARCUS technology, a proprietary genome editing platform, which combines specificity and efficacy, on the development of food, fuel and feed-based products. Precision BioSciences ARCUS technology helps improve genes related to crop quality, yield, and performance traits and strives to advance food products. The company also applies its ARCUS technology to the development of cell-based immunotherapies to cure...

    Add to Basket
  • Company Profile

    $295 | February 2024
    Company Profile

    Can-Fite BioPharma Ltd – Company Profile

    Can-Fite BioPharma Ltd (Can-Fite), is a clinical stage drug development company that strives to develop small-molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheumatoid arthritis and psoriasis, CF102, for hepatocellular carcinoma and CF602, for erectile dysfunction. Can-Fite develops its products by harnessing its technology platform which is based on the Gi protein associated A3 adenosine receptor (A3AR). The company works in...

    Add to Basket
  • Company Profile

    $295 | February 2024
    Company Profile

    Evaxion Biotech A/S – Company Profile

    Evaxion Biotech A/S (Evaxion) is a clinical-stage biotech company that harnesses artificial intelligence (AI) to develop immunotherapies with improved efficiency to treat patients with unmet medical needs. Simulating the human immune system, it strives to develop predictive models to identify and develop customized and other next-generation immunotherapies. The company uses its proprietary AI technologies to decode the human immune system and develop immunotherapies for cancer, bacterial infections and viral infections. Evaxion obtained the pipeline products including personalized cancer immunotherapies and...

    Add to Basket
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.